Matty,
Consider the facts not the speculation.
From today's AGM:
- PAT-DX3 development on HOLD
- PAT-DX1 ethics approval Q3 CY24
- PAT-DX1 clinical trial at best Q4 CY 24 (more likely CY25)
- No tangible business development outcomes identifiable
- No sources of non-dilutive capital identified
- Capital raising CY24 coming
- Presentation includes typos (New Chair joined in Nov 23 Slide 7)
Me thinks time for the "Good Dr" to move on to new pastures.
DYOR
IMO
Clare
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(25.0%) |
Mkt cap ! $3.548M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $112 | 74.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 97850000 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 72992945 | 14 |
View Market Depth
| Last trade - 10.43am 01/08/2025 (20 minute delay) ? |
| PAB (ASX) Chart |